Yeager TR - Search Results

1

Overcoming cellular senescence in human cancer pathogenesis.

Yeager TR, DeVries S, Jarrard DF, Kao C, Nakada SY, Moon TD, Bruskewitz R, Stadler WM, Meisner LF, Gilchrist KW, Newton MA, Waldman FM, Reznikoff CA. Yeager TR, et al. Genes Dev. 1998 Jan 15;12(2):163-74. doi: 10.1101/gad.12.2.163. Genes Dev. 1998. PMID: 9436977 Free PMC article.

2

Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells.

Reznikoff CA, Yeager TR, Belair CD, Savelieva E, Puthenveettil JA, Stadler WM. Reznikoff CA, et al. Among authors: yeager tr. Cancer Res. 1996 Jul 1;56(13):2886-90. Cancer Res. 1996. PMID: 8674033

3

A molecular genetic model of human bladder cancer pathogenesis.

Reznikoff CA, Belair CD, Yeager TR, Savelieva E, Blelloch RH, Puthenveettil JA, Cuthill S. Reznikoff CA, et al. Among authors: yeager tr. Semin Oncol. 1996 Oct;23(5):571-84. Semin Oncol. 1996. PMID: 8893868 Review.

4

p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells.

Jarrard DF, Sarkar S, Shi Y, Yeager TR, Magrane G, Kinoshita H, Nassif N, Meisner L, Newton MA, Waldman FM, Reznikoff CA. Jarrard DF, et al. Among authors: yeager tr. Cancer Res. 1999 Jun 15;59(12):2957-64. Cancer Res. 1999. PMID: 10383161

5

Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.

Sarkar S, Jülicher KP, Burger MS, Della Valle V, Larsen CJ, Yeager TR, Grossman TB, Nickells RW, Protzel C, Jarrard DF, Reznikoff CA. Sarkar S, et al. Among authors: yeager tr. Cancer Res. 2000 Jul 15;60(14):3862-71. Cancer Res. 2000. PMID: 10919661

6

Increased p16 levels correlate with pRb alterations in human urothelial cells.

Yeager T, Stadler W, Belair C, Puthenveettil J, Olopade O, Reznikoff C. Yeager T, et al. Cancer Res. 1995 Feb 1;55(3):493-7. Cancer Res. 1995. PMID: 7834615

7

Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells.

Reznikoff CA, Belair C, Savelieva E, Zhai Y, Pfeifer K, Yeager T, Thompson KJ, DeVries S, Bindley C, Newton MA, et al. Reznikoff CA, et al. Genes Dev. 1994 Sep 15;8(18):2227-40. doi: 10.1101/gad.8.18.2227. Genes Dev. 1994. PMID: 7958891 Free article.

8

Methotrexate resistance in human uroepithelial cells with p53 alterations.

Yeager TR, Reznikoff CA. Yeager TR, et al. J Urol. 1998 Feb;159(2):581-5. doi: 10.1016/s0022-5347(01)63988-0. J Urol. 1998. PMID: 9649296

9

Telomerase activity: a biomarker of cell proliferation, not malignant transformation.

Belair CD, Yeager TR, Lopez PM, Reznikoff CA. Belair CD, et al. Among authors: yeager tr. Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13677-82. doi: 10.1073/pnas.94.25.13677. Proc Natl Acad Sci U S A. 1997. PMID: 9391085 Free PMC article.

10

Telomerase activity in pleural malignant mesotheliomas.

Au AY, Hackl T, Yeager TR, Cohen SB, Pass HI, Harris CC, Reddel RR. Au AY, et al. Among authors: yeager tr. Lung Cancer. 2011 Sep;73(3):283-8. doi: 10.1016/j.lungcan.2010.12.023. Epub 2011 Jan 31. Lung Cancer. 2011. PMID: 21277646 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters